How hydrogen bonds impact P-glycoprotein transport and permeability

被引:111
作者
Desai, Prashant V. [2 ]
Raub, Thomas J. [2 ]
Blanco, Maria-Jesus [1 ]
机构
[1] Eli Lilly & Co, Lilly Res Labs, Discovery Chem Res & Technol, Indianapolis, IN 46285 USA
[2] Eli Lilly & Co, Lilly Res Labs, Drug Disposit, Computat ADME, Indianapolis, IN 46285 USA
关键词
Hydrogen bond; Intramolecular hydrogen bond; P-Glycoprotein; Permeability; HBA; HBD; TPSA; ATP-binding cassette; CENTRAL-NERVOUS-SYSTEM; SPINDLE PROTEIN KSP; PASSIVE MEMBRANE-PERMEABILITY; BLOOD-BRAIN-BARRIER; DRUG DESIGN; RECEPTOR ANTAGONISTS; PEPTIDE STRUCTURE; CACO-2; CELLS; IN-VITRO; INHIBITORS;
D O I
10.1016/j.bmcl.2012.08.059
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The requirement to cross a biological membrane can be a complex process especially if multidrug transporters such as P-gp must be considered. Drug partitioning into the lipid membrane and efflux by P-gp are tightly coupled processes wherein H-bonding interactions play a key role. All H-bond donors and acceptors are not equal in terms of the strength of the H-bonds that they form, hence it is important to consider their relative strength. Using various examples from literature, we illustrate the benefits of considering the relative strengths of individual H-bonds and introducing intramolecular H-bonds to increase membrane permeability and/or decrease P-gp efflux. (C) 2012 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6540 / 6548
页数:9
相关论文
共 66 条
  • [1] P-glycoprotein senses its substrates and the lateral membrane packing density:: Consequences for the catalytic cycle
    Aanismaa, Paivi
    Gatlik-Landwojtowicz, Ewa
    Seelig, Anna
    [J]. BIOCHEMISTRY, 2008, 47 (38) : 10197 - 10207
  • [3] HYDROGEN-BONDING .9. SOLUTE PROTON DONOR AND PROTON ACCEPTOR SCALES FOR USE IN DRUG DESIGN
    ABRAHAM, MH
    DUCE, PP
    PRIOR, DV
    BARRATT, DG
    MORRIS, JJ
    TAYLOR, PJ
    [J]. JOURNAL OF THE CHEMICAL SOCIETY-PERKIN TRANSACTIONS 2, 1989, (10): : 1355 - 1375
  • [4] Application of hydrogen bonding calculations in property based drug design
    Abraham, MH
    Ibrahim, A
    Zissimos, AM
    Zhao, YH
    Comer, J
    Reynolds, DP
    [J]. DRUG DISCOVERY TODAY, 2002, 7 (20) : 1056 - 1063
  • [5] Intramolecular hydrogen bonding to improve membrane permeability and absorption in beyond rule of five chemical space
    Alex, Alexander
    Millan, David S.
    Perez, Manuel
    Wakenhut, Florian
    Whitlock, Gavin A.
    [J]. MEDCHEMCOMM, 2011, 2 (07) : 669 - 674
  • [6] Utilization of an intramolecular hydrogen bond to increase the CNS penetration of an NK1 receptor antagonist
    Ashwood, VA
    Field, MJ
    Horwell, DC
    Julien-Larose, C
    Lewthwaite, RA
    McCleary, S
    Pritchard, MC
    Raphy, J
    Singh, L
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2001, 44 (14) : 2276 - 2285
  • [7] Exploring the P-Glycoprotein Binding Cavity with Polyoxyethylene Alkyl Ethers
    Blatter, Xiaochun Li
    Seelig, Anna
    [J]. BIOPHYSICAL JOURNAL, 2010, 99 (11) : 3589 - 3598
  • [8] A comprehensive non-clinical evaluation of the CNS penetration potential of antimuscarinic agents for the treatment of overactive bladder
    Callegari, Ernesto
    Malhotra, Bimal
    Bungay, Peter J.
    Webster, Rob
    Fenner, Katherine S.
    Kempshall, Sarah
    LaPerle, Jennifer L.
    Michel, Martin C.
    Kay, Gary G.
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 72 (02) : 235 - 246
  • [9] Clark DE, 2011, FUTURE MED CHEM, V3, P469, DOI [10.4155/fmc.11.1, 10.4155/FMC.11.1]
  • [10] Perspectives of P-Glycoprotein Modulating Agents in Oncology and Neurodegenerative Diseases: Pharmaceutical, Biological, and Diagnostic Potentials
    Colabufo, Nicola Antonio
    Berardi, Francesco
    Cantore, Mariangela
    Contino, Marialessandra
    Inglese, Carmela
    Niso, Mauro
    Perrone, Roberto
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2010, 53 (05) : 1883 - 1897